FIELD: chemical; pharmaceutical industry.
SUBSTANCE: invention relates to a dosage form of human albumin in the form of an ointment for external use. The dosage form contains human albumin as an active ingredient, an ointment base and a preservative. It contains a 20% solution of human albumin as an active ingredient, stearic acid as an ointment base, silver citrate and an emulsifier polysorbate 80 as a preservative and additionally contains 96% glycerin and potassium carbonate at a certain ratio of ingredients.
EFFECT: expanding the arsenal of products with anti-burn and wound-healing effect.
1 cl, 4 ex, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
PREPARATION FOR TOPICAL USE FOR IMMUNOSUPPRESSION AND TREATMENT OF AUTOIMMUNE AND ALLERGIC DISEASES | 1996 |
|
RU2156127C2 |
LOCAL COMPOSITION CONTAINING AMBROXOL | 2005 |
|
RU2381794C2 |
AGENT FOR WOUNDS, BURNS AND INFECTIOUS INFLAMMATORY DISEASES OF SKIN, APPENDAGES AND MUCOUS MEMBRANES | 2010 |
|
RU2452475C2 |
PHARMACEUTICAL AGENT FOR ARTHRITIC DISEASES TREATMENT | 2020 |
|
RU2739184C1 |
WOUND HEALING DRUG | 2022 |
|
RU2789196C1 |
PHARMACEUTICAL COMPOSITION FOR TREATMENT OF BURN (VARIANTS) AND METHOD FOR ITS PREPARING (VARIANTS) | 2006 |
|
RU2317811C1 |
COMPOSITION BASED ON ZINC PYRITHIONE AND METHOD OF OBTAINING IT | 2009 |
|
RU2414884C1 |
ANTIVIRAL PHARMACEUTICAL COMPOSITION | 2013 |
|
RU2538082C2 |
PHARMACEUTICAL COMPOSITION CONTAINING VITAMIN D ANALOGUE AND MIXED CO-SOLVENT AND SURFACTANT | 2009 |
|
RU2500387C1 |
METHODS AND COMPOSITIONS FOR TREATING DRY EYE DISEASE AND OTHER EYE DISEASES | 2016 |
|
RU2691412C2 |
Authors
Dates
2023-10-24—Published
2023-05-05—Filed